Abstract
Topical photoallergic contact dermatitis (PACD) is thought to represent a delayed-type hypersensitivity reaction when an exogenous agent combines with some component of the skin in the presence of ultraviolet (UV) and/or visible light.
Although PACD is relatively rare, it is also underdiagnosed as a cause of sunlight-exposed site dermatitis.
Photopatch testing is the investigation of choice for topical PACD, and a European consensus methodology for photopatch testing should allow greater comparison between centers.
Currently, organic UV sunscreen absorbers and topical nonsteroidal anti-inflammatory drugs (NSAIDs) are the commonest photohaptens encountered by patients.
Clinicians should be aware of potential new photohaptens in the environment and have a low threshold for photopatch testing such agents.
References
Aerts O, Clinck B et al (2015) Contact allergy caused by Tinosorb®M: let us not forget about xantham gum. Contact Dermatitis 72:121–123
Anonymous (1997) Photopatch testing-methods and indications. British photodermatology group. Br J Dermatol 136:371–376
Batchelor RJ, Wilkinson SM (2006) Photopatch testing- a retrospective review using the 1 day and 2 day irradiation protocols. Contact Dermatitis 54:75–78
Bell HK, Rhodes LE (2000) Photopatch testing in photosensitive patients. Br J Dermatol 142:589–590
Bourke J, Coulson I et al (2001) British association of dermatologists. Guidelines for care of contact dermatitis. Br J Dermatol 145:877–885
Bruynzeel DP, Ferguson J et al (2004) Photopatch testing: a consensus methodology for Europe. J Eur Acad Dermatol Venereol 18:679–682
Bryden AM, Moseley H et al (2006) Photopatch testing of 1155 patients: results of the U.K. multicentre photopatch study group. Br J Dermatol 155:737–747
Darvay A, White IR et al (2001) Photoallergic contact dermatitis is uncommon. Br J Dermatol 145:597–601
Diaz RL, Gardeazabal J et al (2006) Greater allergenicity of topical ketoprofen in contact dermatitis confirmed by use. Contact Dermatitis 54:239–243
EMCPPTS Taskforce (2012) A European multi-centre photopatch test study. Br J Dermatol 166:1002–1009
Epstein S (1939) Photoallergy and primary photosensitivity to sulfanilamide. J Invest Dermatol 2:43–51
Epstein S (1968) Chlorpromazine photosensitivity. Phototoxic and photoallergic reactions. Arch Dermatol 98:354–363
European Commission, Growth, CosIng Annex VII, Part 1 – List of permitted UV filters which cosmetic products may contain (Last updated 2010). http://ec.europa.eu/growth/tools-databases/cosing/pdf/COSING_Annex%20VII_v1_part1.pdf. Accessed 6 Mar 2017
European Medicines Agency (2010) Ketoprofen topical. Outcome of a procedure under Article 107 of Directive 2001/83/EC. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Ketoprofen_topical/human_referral_000238.jsp&mid=WC0b01ac05805c516f. Accessed 10 Mar 2017
Girardin P, Vigan M et al (2006) Cross-reactions in patch testing with ketoprofen, fragrance mix and cinnamic derivatives. Contact Dermatitis 55:126–128
Goncalo M, Ferguson J et al (2013) Photopatch testing: recommendations for a European photopatch test baseline series. Contact Dermatitis 68:239–243
de Groot AC (1994) Patch testing: test concentrations and vehicles for 3700 chemicals, 2nd edn. Elsevier, New York
de Groot AC, Roberts DW (2014) Contact and photocontact allergy to octocrylene: a review. Contact Dermatitis 70:193–204
Guy RH, Maibach HI (1983) Drug delivery to local subcutaneous structures following topical administration. J Pharm Sci 72:1375–1380
Hindsen M, Isaksson M et al (2004) Photoallergic contact dermatitis from ketoprofen induced by drug-contaminated personal objects. J Am Acad Dermatol 50:215–219
Hindsen M, Zimerson E et al (2006) Photoallergic contact dermatitis from ketoprofen in southern Sweden. Contact Dermatitis 54:150–157
Holman M, Shetty D (2005) The role of FDA in sunscreen regulation. In: Shaath NA (ed) Sunscreens. Regulations and commercial development. Cosmetic and technology series, vol 28, 3rd edn. Taylor & Francis, London
Kerr AC, Muller F et al (2008) Occupational carprofen photoallergic contact dermatitis. Br J Dermatol 159: 1303–1308
Kerr AC, Niklasson B et al (2009) A double-blind, randomized assessment of the irritant potential of sunscreen chemical dilutions used in photopatch testing. Contact Dermatitis 60:203–209
Le Coz CJ, Bottlaender A et al (1998) Photocontact dermatitis from ketoprofen and tiaprofenic acid: cross-reactivity study in 12 consecutive patients. Contact Dermatitis 38:245–252
Leroy D, Dompmartin A et al (1997) Photodermatitis from ketoprofen with cross-reactivity to fenofibrate and benzophenones. Photodermatol Photoimmunol Photomed 13:93–97
Liuti F, Borrego L (2015) Contact dermatitis caused by Tinosorb®M: the importance of testing with pure methylene bis-benzotriazolyl tetramethylbutylphenol. Contact Dermatitis 73:192–193
Mascotto RE (2005) Regulatory aspects of sunscreens in Europe. In: Shaath NA (ed) Sunscreens. Regulations and commercial development. Cosmetic and technology series, vol 28, 3rd edn. Taylor & Francis, London
Mesa MCV, Jimenez EVH (2016) Photopatch testing in Bogota (Colombia): 2011–2013. Contact Dermatitis 74:11–17
Murphy EG (2005) The final monograph. In: Shaath NA (ed) Sunscreens. Regulations and commercial development. Cosmetic and technology series, vol 28, 3rd edn. Taylor & Francis, London
Ophaswongse S, Maibach H (1993) Topical nonsteroidal antiinflammatory drugs: allergic and photoallergic contact dermatitis and phototoxicity. Contact Dermatitis 29:57–64
Raugi GJ, Storrs FJ et al (1979) Photoallergic contact dermatitis to men’s perfumes. Contact Dermatitis 5:251–260
Schauder S, Ippen H (1997) Contact and photocontact sensitivity to sunscreens. Review of a 15-year experience and of the literature. Contact Dermatitis 37:221–232
Schauder S, Schroder W et al (1996) Olaquindox-induced airborne photoallergic contact dermatitis followed by transient or persistent light reactions in 15 pig breeders. Contact Dermatitis 35:344–354
Scott KW, Dawson TA (1974) Photo-contact dermatitis arising from the presence of quindoxin in animal feeding stuffs. Br J Dermatol 90:543–546
U.S. Food and Drug Administration (1999) Rulemaking history for OTC sunscreen drug products. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Over-the-CounterOTCDrugs/StatusofOTCRulemakings/ucm072134.htm. Accessed 6 Mar 2017
U.S. Food and Drug Administration (2014) Sunscreen Innovation Act (SIA). https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/ucm434782.htm. Accessed 9 Mar 2017
Wahlberg JE (2001) Patch testing. In: Rycroft R, Menne T, Frosch P, Lepoittevin J-P (eds) Textbook of contact dermatitis, 3rd edn. Springer, Berlin
Wilkinson DS (1961) Photodermatitis due to tetrachlorsalicylanilide. Br J Dermatol 73:213–219
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this entry
Cite this entry
Ferguson, J., Kerr, A.C. (2018). Photoallergic Contact Dermatitis. In: John, S., Johansen, J., Rustemeyer, T., Elsner, P., Maibach, H. (eds) Kanerva’s Occupational Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-40221-5_16-2
Download citation
DOI: https://doi.org/10.1007/978-3-319-40221-5_16-2
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-40221-5
Online ISBN: 978-3-319-40221-5
eBook Packages: Springer Reference MedicineReference Module Medicine